ANIP - ANI Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue201,576176,842128,62276,322
Cost of Revenue67,33568,63242,88012,692
Gross Profit134,241108,21085,74263,630
Operating Expenses
Research Development15,3889,0702,9062,874
Selling General and Administrative42,69131,58026,52921,156
Non Recurring----
Others----
Total Operating Expenses159,156137,21094,65843,622
Operating Income or Loss42,42039,63233,96432,700
Income from Continuing Operations
Total Other Income/Expenses Net-22,369-23,283-25,286-10,967
Earnings Before Interest and Taxes42,42039,63233,96432,700
Interest Expense-14,758-11,924-11,294-11,143
Income Before Tax20,05116,3498,67821,733
Income Tax Expense4,55717,4254,7446,358
Minority Interest----
Net Income From Continuing Ops15,494-1,0763,93415,375
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income15,494-1,0763,93415,375
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares15,494-1,0763,91315,290